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Abstract 
      The aim of this study is to determine in vivo response of topical Epigallocatechin-3-gallate 
(EGCG) hydrogels to pain and inflammation through Toll-like receptor 4 (TLR4), Superoxide 
dismutase (SOD1), Prostaglandin E2 (PG-E2) and Transient receptor potential vanilloid 1 (TRPV1) 
in pulpal inflammation. 
      Rats (n=35) were divided into a normal group (N), a positive control group induced with LPS for 
6 hours (C1), a group induced with LPS for 24 hours (C2), a treatment group induced with LPS and 
topical EGCG 120 µg/ml (T1) for 6 hours and a group induced with LPS and topical EGCG 120 
µg/ml for 24 hours (T2). Tissues were collected and observed by means of immunohistochemistry 
(IHC) to detect the expression of TLR4, SOD1, PG-E2 and TRPV1.  Data were analyzed using a 
One-Way ANOVA test for TLR4, PG-E2 and TRPV1, while SOD1 was analyzed using a Brown-
Forsythe test and Games Howell test.  
      Application of topical 120 µg/ml EGCG hydrogels in tooth cavities at 6 hours and 24 hours 
pulpal inflammation significantly increased the expression of SOD1, while significantly decreasing 
the expressions of TLR4, PG-E2 and TRPV1 (P< 0.001).  EGCG can be used as a pain inhibitor, 
anti-inflammatory agent and antioxidant agent against pulpal inflammation in rat models.   
Experimental article (J Int Dent Med Res 2019; 12(1): 54-60)          
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 Introduction 
 
 Pulpal inflammation is a pulp disease 
characterized by pain in the trigeminal nociceptor.1 
One of the causative factors in acute pulpal 
inflammation is lipopolysaccharide (LPS) which 
activates macrophages through Toll-like receptor 
4 (TLR4). This activation leads to gene 
transcription of Tumor Necrosis Factor-α (TNF-α). 
The expressions of TLR4 and TNF-α will 
increase within 6 hours after LPS induction, 
reaching a peak after 24 hours.2  
 Macrophage is activated during pulpal 
inflammation. The metabolism of macrophages 
can trigger production of reactive oxygen species 
(ROS). Low to moderate concentrations of ROS 
are important for physiological cell processes. 
High concentrations of ROS may lead to adverse 
modifications to cell components, such as lipids 
and proteins, which may cause changes in 
deoxyribonucleid acid (DNA) structure. ROS can 
induce lipid peroxidation and disrupt the 
membrane lipid bilayer .3 
Humans produce endogenous 
antioxidants to neutralize oxidants. The major 
enzymatic antioxidants are superoxide dismutase 
(SOD1), catalase (CAT) and glutathione 
peroxidase (GSH-Px).3,4 The increased level of 
SOD1 will catalyze 2O2
* and 2H+ into H2O2 and O2. 
High expressions of CAT will catalyze H2O2 into 
H2O and O2.
5 Cell membrane regulation for cell 
damage repair also produces ROS. Effective 
antioxidants should immediately be administered 
to maintain membrane integrity. High levels of 
ROS accompanied by the presence of 
cyclooxygenase (COX2) enzyme will lead to 
catalyzation of arachidonic acid (AA) into 
prostaglandin-E2 (PG-E2).6 The expression of 
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PG-E2 activates transient receptor potential 
vanilloid (TRPV1) in the sensory nerve endings 
of dental pulps located in the outer surface 
sodium gated channel. The up-regulation of 
TRPV1 in trigeminal nociceptors can contribute 
to hyperalgesia under pulpitis conditions.6 Pulp 
tissue is located inside the pulp chamber and 
surrounded by a hard dentine wall. Blood supply 
and drainage pass through narrow apical 
foramen. This condition may accelerate 
inflammation and death of the pulp tissue.8 In 
addition, early treatment is needed to inhibit the 
progress of inflammation in order that endodontic 
treatment can be rendered unnecessary. 
One of the widely used medicaments in 
the field of dentistry is eugenol that contains an 
active component, known as phenol. Eugenol 
has been a popular medicament as topical pain 
relievers to alleviate toothache and dentin 
hypersensitivity, for pulp capping material or root 
canal obturation material. However, eugenol is 
not entirely a biocompatible material due to 
previous studies that showed eugenol dressing 
for 2-3 days had side effect of ulceration and 
within 48 hours leading to painful ulcer with 
surrounding erythema. Furthermore, within 2 
months will lead to tooth necrosis.9 It is, therefore, 
necessary to identify alternative materials for 
dental medicament. 
Epigallocatechin-3-gallate (EGCG) 
contains an active component, known as 
polyphenol, that is classified as a catechin. 
EGCG is an interesting subject of study due to its 
flavanoid content which can inhibit the opening of 
the Natrium (Na+) ion channel and its potential 
action.10 In addition, EGCG can act as an 
antioxidant  and anti-inflammatory agent.11-13 
Catechin of EGCG can reduce the level of free 
radicals and also prevent their chain reactions 
because EGCG can bind itself to ROS.12 EGCG 
capable of passively diffusing into the cell 
cytoplasm and nucleus through protein pore 
channels in the cell membrane and EGCG 
directly binds to membrane component including 
protein and lipid.14-15 EGCG flavonoid can bind 
with 67-kDa laminin receptor (LR) in macrophage 
cell membranes , inhibit LPS is to mediate anti-
inflammatory action and decrease of TLR4, and 
trigger SOD1 and CAT gene transcription.16-20 
The aim of this study is to determine the extent of 
the in vivo response of topical EGCG hydrogels 
at a concentration of 120 µg/ml because, based 
on previous results, the concentration showed 
more than 50% cell viability of TLR4, SOD1, PG-
E2 and TRPV1 present in pulpal inflammation in 
Wistar rat models.  
   
Materials and methods 
 
 Rats (Rattus norvegicus) male (n=35) 
aged 2.5 months and weighing 22-30 grams 
were obtained from the Department of Medical 
Biochemistry, Faculty of Medicine, Universitas 
Airlangga, Surabaya, Indonesia. The study 
reported here was approved and supervised by 
the Universitas Airlangga Faculty of Dental 
Medicine Research Ethical Clearance 
Commision, No 018/HRECC.FODM/ III/2018. 
The rats were divided into a normal group 
(N) without LPS and EGCG application, a 
positive control group (C1) induced with LPS for 
6 hours, a control group (C2) induced with LPS 
for 24 hours and a treatment group (T1) induced 
with LPS and topical EGCG 120 µg/ml for 6 
hours and T2 induced with LPS and topical 
EGCG 120 µg/ ml for 24 hours. Each subject in 
groups C1, C2, T1 and T2 was anesthetized 
intra-muscularly with 0.2 cc taken from a mixture 
of 0.5 cc of ketamine (Ketalar®, PT.Pfizer 
Indonesia) and 0.5 cc of xylazine (Xyla®, PT 
Tekad Mandiri Citra, Indonesia). A 1.5mm deep 
cavity with a diameter of 2mm was created in the 
maxillary left first molar with a new sterile 
fissurotomy bur (SS White burs Inc., Lakewood, 
NJ, USA) using a high-speed contraangle (W&H 
Dentalwerk Burmoos GmbH, Austria). The 
resulting cavities were subsequently irrigated 
with sterile saline solution and dried with sterile 
cotton rolls. Fine paper points were used to 
carefully inspect any sign of exposure of the pulp 
horn, such as bleeding from the tooth pulp.7 
 An acute pulpal inflammation model was 
created using LPS (derived from Escherichia coli 
(E.coli), serotype 0111: B4, Sigma Chemical Co, 
St. Louis, MO, USA; 10 mg/ml; product number 
L2630). The LPS was then diluted to a 
concentration of 10 µg/µl, a volume of 0.5 µl and 
applied using a fine flattened microbrush 
(Microbrush, USA) before being allowed to dry. 
This wet and dry procedure was repeated five 
times.7) The N group observed was without LPS 
induction. The C1 and T1 groups were induced 
with LPS for 6 hours, with each cavity being 
sealed with GIC (Fuji 7, GC Corp, Tokyo, Japan). 
Groups C2 and T2 were induced with LPS for 24 
hours and the cavity was then sealed with GIC. 
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 After LPS induction, the GIC restorations 
were disassembled to open the cavity. EGCG 
was then applied (Xi'An Rongsheng 
Biotechnology, China, 2013101512 RS) at a 
concentration of 120 µg/ml in the form of PEG 
hydrogels (PEG 400 and 4000) (Sigma-Aldrich, 
25322-68-3). Base compounds for PEG 400 and 
PEG 4000 were measured at a ratio of 5:1. From 
the calculations, the PEG 400 base was 
determined at 83.33 grams and the PEG 4000 
base at 16.67 grams. Both were poured into a 
porcelain cup, mixed under heat using a hot plate 
at a temperature of 100 °C, stirred until 
homogenous and allowed to cool. Up to1200 µg 
of EGCG was then poured into 10mL of PEG 
mixture and stirred until homogenous. In groups 
C1 and C2, 0.5 ml PEG hydrogels were applied 
to the tooth cavities. Meanwhile, in groups T1 
and T2, 0.5 ml of 120 µg/ml EGCG hydrogels 
was applied to the respective tooth cavities, prior 
to their being sealed with GIC restoration. After 
24 hours, the administration of PEG was 
repeated for groups C1 and C2, while EGCG 
hydrogels was repeatedly administered to groups 
T1 and T2. The cavity was sealed with GIC 
restoration and allowed to settle for 24 hours.  
 The subjects in groups C1 and T1 were 
sacrified 54 hours after the dentinal application of 
LPS, while those in the C2 and T2 groups were 
sacrified after 72 hours. The subjects in group N 
were sacrificed after 72 hours along with those in 
groups C2 and T2. The left maxillary first molars 
were then surgically removed along with the 
upper jaw to be used as specimens for analysis, 
the unit of analysis being dental pulp. IHC 
staining technique was employed to examine the 
expression of TLR4 (anti-rat TLR4 monoclonal 
antibody, Santa Cruz Biotechnology Inc., USA), 
SOD1 (anti-rat SOD1 monoclonal antibody Santa 
Cruz Biotechnology Inc., USA), PG-E2 (anti-rat 
PG-E2 polyclonal antibody Primary Conjugated, 
Bioss, USA) and TRPV1 (anti-rat TRPV1 
monoclonal antibody, NeuroMab, USA). Two 
operators were blinded to the samples. They 
were not informed about the identity of the 
samples. Operators uniformed as to the 
technique employed examined the samples. 
Samples were observed using a light microscope 
E 100 at 400x magnification from five perspective 
points (Nikon, Tokyo, Japan).  
 
The surface area of the cells was 
calculated through observation. In each group, 
the number of  TLR4, PG-E2, macrophage cells 
and TRPV1 sensory nerve cell expressions was 
recorded. The images were captured with a 
digital camera (A7; Sony, Tokyo, Japan) (Figure 
1). The homogenity of the distribution of data 
obtained was then analyzed by means of a One-
sample Kolmogorov-Smirnov Test, in 
combination with a Levene test. A One-Way 
Analyses of Variance (ANOVA) test and 
Comparative Analysis of Least Significance 
Difference (LSD) were performed on the TLR4, 
PG-E2 and TRPV1 data, while a Brown-Forsythe 
test and Games Howell test were performed on 
the SOD1 data. 
 
 
Figure 1. IHC result for TLR4, SOD1, PG-E2 
expressions in macrophages cells and TRPV1 in 
sensory nerve cell expressions. The red arrows 
indicate positive expressions and examples of 
cells that were counted. 
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Results 
 
The test showed that all the data in this 
research were normally distributed (P>0.05). A 
homogenity test using a Levene test confirmed 
the data of TLR4, PG-E2 and TRPV1 as 
homogenous (P>0.05). In contrast, the data of 
SOD1 expressions did not demonstrate 
homogenous variance (P<0.05). A One-Way 
ANOVA test and Comparative Analysis of LSD 
(P<0.001) were performed on the TLR4, PG-E2 
and TRPV1 data. A Brown-Forsythe test and 
Games Howell comparation test were performed 
on the SOD1 data the results of which are shown 
in Table 1. The induction of LPS for 6 hours and 
24 hours produced a significant increase in the 
expression of TLR4, SOD1, PG-E2 and TRPV1 
(P< 0.001). The topical application of 120 µg/ml 
EGCG hydrogels on 6-hour and 24-hour pulpal 
inflammation produced significant inhibition in the 
expression of TLR4, PG-E2 and TRPV1. There 
was significantly increased expression of SOD1 
(P<0.001). 
 
 Discussion 
 
 Bacterial products such as LPS may 
activate macrophages cells through TLR4.2 
Activation of macrophages cells may increase 
the level of ROS   which will catalyze AA into PG-
E2.3,6 The activation of PG-E2 will activate 
TRPV1 in the sensory nerve endings mof the 
dental pulp which contributes to hyperalgesia 
under conditions of pulpitis.7 
 In this research, a pulpitis model was 
created by means of inducing LPS from E.coli to 
freshly cut dentin in the maxillary left first molar. 
The research method applied during this 
procedure was non-invasive in order to induce 
pulpal inflammation, while minimizing any risk of 
pulpal injury, and to observe only the effects of 
LPS application without disruption to other 
unknown inflammation sources.7 The results of 
this research showed that TLR4, SOD1, PG-E2 
and TRPV1 expressions occurred in the normal 
group. 
In the groups experiencing 6-hour pulpal 
inflammation, the following approximate increases 
occurred: 2.75-fold in the expression of TLR4, 
1.72-fold in SOD1, 3.40-fold increase in PG-E2 
and 2.66-fold in TRPV1. In the groups experiencing 
24-hour pulpal inflammation demonstrated the 
following approximate increases: 0.75-fold in the 
expression of TLR4, 2.72-fold in SOD1, 8.8-fold 
in PG-E2, and 7.00-fold in TRPV1 compared with 
the normal group. This study demonstrated that 
the dentinal application of LPS up-regulated 
TLR4, SOD1, PG-E2 in macrophage cells and 
TRPV1 presetn in the sensory nerve cells 
present in dental pulp. In the 24-hour pulpal 
inflammation groups, the following approximate 
increases occurred: 3.90-fold in TLR4 
expression, 1.57-fold SOD1, 2.58-fold in PG-E2 
and 2.62-fold in TRPV1, compared to the 6-hour 
pulpal inflammation model. These figure indicate 
that in 6-hour acute pulpal inflammation, the 
degree of inflammation remained low, with the 
result that the production of TLR4, SOD1, PG-
E2, and TRPV1 was also limited. The results 
obtained show that the elevated level of 
inflammation could increase the expressions of 
TLR4, SOD1, PG-E2, and TRPV1. A higher level 
of inflammation can trigger the production of 
ROS, cell damage, lead to an increase in the 
recruitment of endogenous antioxidant enzymes, 
such as SOD1, and trigger pain.  
The antioxidant activity and direct role as 
a free radical scavenger of EGCG has the 
potential to indirectly stimulate SOD1 and CAT, 
thereby increasing their anti-inflammatory , and 
analgesic.10,13,19,20 In this research, EGCG was 
present in the form of hydrogels. The delivery 
system applied in this research was liquid PEG 
400 mixed with solid PEG 4000. The use of a 
biocompatible polymer such as PEG was 
expected to maintain cell stability and viability, 
while also controlling the release of EGCG.21 
Therefore, the absorption of EGCG will become 
slower, more continuous, more stable and more 
evenly spread in order to extend the half-life time. 
In addition, other benefits include: enhanced 
bioavailability, a minimal absorption rate, 
protection of the drug against the environment 
and avoiding the stimulation of, and increasing 
affinity between, hydrogen and oxygen.22-24 
The results showed acute pulpal 
inflammation leading to an increase in SOD1, 
and decreases in the TLR4 and PG-E2 
expressions of macrophage cells and TRPV1 in 
sensory nerve cells. 24-hour acute pulpal 
inflammation led to a greater increase in SOD1 
and a more pronounced decrease in TLR4 and 
PG-E2 expression in macrophage cells and 
reduction in the TRPV1 present in sensory nerve 
cells than 6-hour acute pulpal inflammation. 
Topical application of EGCG at a concentration 
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of 120 μg/ml in 6-hour acute pulpal inflammation 
led to an approximate 1.27-fold inhibition of TLR4 
expressions, while in the 24-hour acute pulpal 
inflammation it led to an approximate 2.38-fold 
inhibition in TLR4 expression. The results of this 
study are in accordance with those of previous 
research which stated that the galloyl structure of 
EGCG will inhibit the activity of peptidase and 
collagenase in LPS, thereby preventing activation 
of TLR4.25 Polyphenol derived from EGCG 
caused the inhibition of protease activity in LPS 
resulting in a decrease in LPS and consequent 
reduction in TLR4 expression,26 EGCG increases 
the activity of alkaline phosphatase (ALP) and 
leads to the dephosphorylation of phosphate 
groups on LPS surfaces. This, in turn, produces 
the fatty acid lipid A chain of LPS which, initially a 
hexa acylated lipid A, becomes penta or tetra 
acylated lipid A. This results in decreasing LPS 
immunogenity to the point that there is no signal 
to activate. Chen EGCG can inhibit the synthesis 
of fatty acids that, themselves, inhibit the 
production of toxins.27 
 Topical application of EGCG at a 
concentration of 120 µg/ml in 6-hour acute pulpal 
inflammation led to an approximate 1.68-fold 
increase in SOD1 expression, while the 24-hour 
acute pulpal inflammation precipitated an 
approximate 2.06-fold increase in SOD1 
expression. Increased expression of SOD1 
indicates a high potential for dismutase activity, 
turning superoxide into less reactive hydrogen 
peroxide.14 Higher expression of SOD1 in the 24-
hour acute pulpal inflammation model compared 
to the 6-hour acute pulpal inflammation model 
indicates a high ROS level in 24-hour acute 
pulpal inflammation. It also suggests greater 
physiological responses than the stimulus which 
is probably intended to offer protection and as a 
SOD1 backup in responding to ROS. The 
increased SOD1 expression may be caused by 
SOD1 gene activation.28 This is due to the fact 
that SOD1 can cause the dismutase of 2O2
* + 
2H+ into H2O2 and O2, with the result that O2
* will 
decrease.5 The antioxidant activity of CAT then 
finalizes the activities of SOD1 since H2O2 is 
catalyzed by CAT into H2O and O2.
4,5 The 
prevention of new free radical formation plays a 
role in preventing tissue redox balance 
disruption, regulating the signaling molecule for a 
balanced physiological process.5 The accumulation 
of ROS will then damage polyunsaturated lipid A 
(PUFA) through disruption of the integrity of cell 
membranes by membrane lipid peroxidation and 
leads to rearrangement of membrane structure.3 
This research proved that the accumulation of 
ROS can be inhibited by EGCG, as well as by 
the the increased expression of SOD1.  
As a result, the application of EGCG at a 
concentration of 120 µg/ml in acute 6-hour pulpal 
inflammation triggered a significant approximate 
1.54-fold decrease in the expression of PG-E2, 
while in 24-hour acute pulpal inflammation, the 
expression of PG-E2 decreased to an even 
greater extent, reaching about 1.69-fold. 
Activation of the phospholipase A2 (PLA) 
enzyme will catalyze the reaction of AA formation 
in the cell lipid membrane, while the presence of 
COX2 and free radicals will catalyze AA to PG-
E2.6 The decreased expression of PG-E2 was 
due to the inhibition of ROS production caused 
by the influence of EGCG, thus inhibiting AA 
catalysis to synthesize PG-E2. This is in 
accordance with the findings of this study that the 
application of EGCG in a 6-hour or 24-hour acute 
pulpitis model will cause increased expression of 
SOD1. This subsequently plays a role in reducing 
ROS and acting as scavenger, thereby 
decreasing ROS and inhibiting AA catalysis to 
synthesize PG-E2. The presence of saponins 
and flavanoids in EGCG can inhibit COX2 
synthesis, consequently decreasing the synthesis 
of PG-E2.10,29 EGCG inhibits the activity of 
phosphorylation of IKK, resulting in the inhibition 
of IκB and, consequently, decreasing the activity 
of NFκB, TNF-α, NO, ROS, and COX2.30  
 The findings of this research show that 
the topical application of EGCG at a 
concentration of 120 µg/ml in a 6-hour acute 
pulpal inflammation model produced an 
approximate 1.6-fold inhibition of TRPV1 
expression, while in the 24-hour acute pulpal 
inflammation model, it resulted in an approximate 
2-fold inhibition of TRPV1 expression. TRPV1 is 
a transmembrane receptor located on the outer 
surface of the complex gated sodium channel on 
the sensory nerve endings of the A- δ fibers in 
dental pulp. Increased TRPV1 expression plays a 
role in acute inflammation.7 Inhibition of TRPV1 
expression is caused by MAPKs activation of 
EGCG resulting in the inhibition of transcription 
factor p65 NF-κB and the inhibiting of TNF-α, 
COX2 and PG-E2 expression. Byun EGCG can 
inhibit the opening of Na + ion voltage-activated 
channels.10,31 The phenol group may interact with 
the vanilloid receptors in the afferent nerve to 
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block nerve action potential, thereby blocking the 
opening of ion channels.32 Stimulation of PG-E2 
on TRPV1 causes membrane depolarization. 
Therefore, the sodium ion channel / channel will 
open, allowing Na + ions to enter the sensory 
nerve cells.33 The influx of Na + ions causes an 
action potential. Thus, neuropeptides SP and 
CGRP, neurotransmitters located in the synaptic 
cleft, are released.14 The more Na + ions enter 
the cell, the greater the potential for the 
membrane to increase and the wider the sodium 
channel openings, allowing more Na + ions to 
enter the cells and cause higher TRPV1 
expression.34  
 
 Conclusions 
 
 EGCG can be used as an anti-
inflammatory agent because EGCG can 
significantly decrease the expressions of TLR4 
and PG-E2. EGCG can also be used as an 
antioxidant because of its ability to significantly 
increase expressions of SOD1. In addition, 
EGCG can be used as a pain inhibitor due to 
decreased expressions of TRPV1 in rat pulpal 
inflammation models. 
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Group   N TLR4 SOD1 PG-E2 TRPV1 
  Mean±SD  Mean±SD  Mean±SD  Mean±SD  
N 7 0.800.20
a
 
 
 
 
< 0.001 
2.200.52
a
 
 
 
 
< 0.001 
1.000.27
a
 
 
 
 
< 0.001 
1.200.53
a
 
 
 
 
< 0.001 
C1 7 2.200.55
b
 3.800.11
b
 3.400.98
c
 3.201.08
c
 
C2 7 8.601.03
d
 6.001.65
c
 8.801.25
e
 8.402.15
d
 
T1 7 1.730.43
c
 6.401.78
c
 2.201.37
b
 2.000.71
b
 
T2 7 3.60 1.12
b
 12.401.33
d
 5.200.98
d
 4.201.04
c
 
Table 1. The Results of TLR4, SOD1, PG-E2 and TRPV1 Expression. 
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